Casals Gemma, Ordi Jaume, Creus Montserrat, Fábregues Francisco, Casamitjana Roser, Quinto Llorenç, Campo Elias, Balasch Juan
Department of Obstetrics and Gynecology, Faculty of Medicine, University of Barcelona, Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
Reprod Biomed Online. 2008 Jun;16(6):808-16. doi: 10.1016/s1472-6483(10)60146-0.
Osteopontin and its receptor alpha(v)beta(3) integrin have recently been proposed as a major complex to promote embryo attachment, and thus they would be useful as markers of endometrial receptivity. In the current study alpha(v)beta(3) integrin and osteopontin expression and co-expression in in-phase and out-of-phase endometrial biopsies from normal healthy women (n = 12) and infertile patients (n = 107) were investigated. Two endometrial biopsies (post-ovulatory day +6 to +8, and 4 days later) were performed during a single menstrual cycle in each subject. Oestradiol and progesterone serum concentrations were quantified on the same days as endometrial sampling. No statistically significant difference regarding alpha(v)beta(3) integrin and osteopontin expression and their coexpression was found between fertile controls and infertile patients irrespective of endometria being in-phase or out-of-phase, infertility factors detected or whether patients became spontaneously pregnant or not. Although a co-ordinate high concentration of both glycoproteins on post-ovulatory day 8 onwards was observed, there was an evident lack of temporal co-expression of these markers during the implantation window. It is concluded that the functional significance of the osteopontin:alpha(v)beta(3) integrin complex as a marker of endometrial receptivity and implantation potential in women seems to be untenable.
骨桥蛋白及其受体α(v)β(3)整合素最近被认为是促进胚胎着床的主要复合物,因此它们可作为子宫内膜容受性的标志物。在本研究中,对正常健康女性(n = 12)和不孕患者(n = 107)的增殖期和分泌期子宫内膜活检组织中α(v)β(3)整合素和骨桥蛋白的表达及共表达情况进行了研究。在每个受试者的单个月经周期内进行两次子宫内膜活检(排卵后第6至8天,以及4天后)。在进行子宫内膜采样的同一天对血清雌二醇和孕酮浓度进行定量。无论子宫内膜处于增殖期还是分泌期、检测到的不孕因素如何,以及患者是否自然受孕,在有生育能力的对照组和不孕患者之间,关于α(v)β(3)整合素和骨桥蛋白的表达及其共表达均未发现统计学上的显著差异。尽管在排卵后第8天及以后观察到两种糖蛋白的浓度同时升高,但在着床窗口期这些标志物明显缺乏时间上的共表达。结论是,骨桥蛋白:α(v)β(3)整合素复合物作为女性子宫内膜容受性和着床潜能标志物的功能意义似乎难以成立。